Anticoagulation in high-risk patients: When is this approach not worth the risk?

American Journal of Medicine

Volumn 109, Issue 4, 2000, Pages 335-337

  Hambleton, Julie ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT THERAPY; BLEEDING; DEEP VEIN THROMBOSIS; HIGH RISK POPULATION; HUMAN; LUNG EMBOLISM; PRIORITY JOURNAL; SHORT SURVEY; THROMBOEMBOLISM; TREATMENT INDICATION;

EID: 0033835783     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(00)00542-8     Document Type: Editorial

References (15)

1. Stein P., Hull R., Raskob G. Withholding treatment in patients with acute pulmonary embolism who have a high risk of bleeding and negative serial noninvasive leg tests. Am J Med. 109:2000;301-306.
2. Wells P., Ginsberg J., Anderson D., et al. Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med. 129:1998;997-1005.
3. Hull R., Raskob G., Ginsberg J., et al. A noninvasive strategy for the treatment of patients with suspected pulmonary embolism. Arch Intern Med. 154:1994;289-297.
4. Investigators P. Value of the ventilation/perfusion scan in acute pulmonary embolism. JAMA. 263:1990;2753-2759.
5. Goldhaber S. Pulmonary embolism. N Engl J Med. 339:1998;93-104.
6. Stein P., Henry J., Relyea B. Untreated patients with pulmonary embolism. Chest. 107:1995;931-935.
7. Levine M., Raskob G., Landefeld C., Kearon C. Hemorrhagic complications of anticoagulant treatment. Chest. 114:(suppl):1998;S511-S523.
8. Landefeld C., McGuire E., Rosenblatt M. A bleeding risk index for estimating the probability of major bleeding in hospitalized patients starting anticoagulant therapy. Am J Med. 89:1990;569-578.
9. Fihn S., McDonell M., Martin D., et al. Risk factors for complications of chronic anticoagulation a multicenter study . Ann Intern Med. 118:1993;511-520.
10. Landefeld C., Beyth R. Anticoagulant-related bleeding clinical epidemiology, prediction, and prevention . Am J Med. 95:1993;315-328.
11. Gitter M., Jaeger T., Petterson T., et al. Bleeding and thromboembolism during anticoagulant therapy a population-based study in Rochester, Minnesota . Mayo Clin Proc. 70:1995;725-733.
12. Kuijer P., Hutten B., Prins M., Buller H. Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism. Arch Intern Med. 159:1999;457-460.
13. Hull R., Raskob G., Rosenbloom D., et al. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med. 322:1990;1260-1264.
14. Kearon C., Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med. 336:1997;1506-1511.
15. Lazio B., Simard J. Anticoagulation in neurosurgical patients. Neurosurgery. 45:1999;838-848.